Rough Skin Renewal Cream

1. INCI & CAS

INCI: Glycerin · CAS: 56-81-5

2. Role in the formula

For emulsions, gels, and washes, this guide assigns glycerin a polyol-humectant role. Its level is not a batch assay.

3. Typical use levels (formulation guide)

• The gels and serums use-level reference is 3–8%.
• Formulation guidance for creams: 2–5% in this reference.
• For rinse-off, the recorded level is 2–4% for the formula.

The water phase is the addition point for Glycerin; a separate melt is unnecessary.

4. Regulatory sources & global compliance

• The CosIng record for Glycerin, where listed, is informational rather than product-specific authorization.
• The finished-product provisions of Regulation (EC) No 1223/2009 require a safety review of the finished cosmetic in which Glycerin is used for the specific product as it will be marketed.
• Verify the purchased Glycerin grade using supplier data, alongside the applicable filing rules for the destination market.

5. Safety & risk assessment

Read the recorded level as a cosmetic formulation guide; it makes no claim of drug or OTC authorization while finished-product patch and stability testing remain necessary.

6. Stability & packaging

Use cool, sealed storage away from strong light for the bulk; review airless or pump options if oxidation presents a concern; follow with stability and packaging checks on the confirmed batch.

7. Claims language (Do / Don’t)

• The cosmetic concept for Glycerin in this entry centers on humectant function.

• This reference does not establish drug effects, clinical cures, or unsupported product certifications.
• The documented facts for Glycerin does not demonstrate skin whitening, acne care, sweat reduction, sun protection, or hair-growth outcomes.

1. INCI & CAS

INCI: Squalane · CAS: 111-01-3

2. Role in the formula

This reference identifies squalane as a stable hydrocarbon emollient and calls for a plant-derived grade, not mineral oil.

3. Typical use levels (formulation guide)

• For gel-creams, use 2–6% in this reference.
• Formulation guidance for dry oils: 10–30%.
• The level shown for balms is 5–15%.

Add Squalane to the oil phase; no high-shear wax step is required.

4. Regulatory sources & global compliance

• CosIng provides reference information for Squalane; confirm the specific grade and intended use against market requirements.
• Regulation (EC) No 1223/2009 sets the requirement for a safety review of the finished cosmetic in which Squalane is used before release of the finished cosmetic.
• Establish grade-specific details for Squalane from the supplier and assess filing requirements in the intended market.

5. Safety & risk assessment

The stated concentration is a cosmetic-development reference; this reference is not approval for drug use or OTC marketing and the completed cosmetic needs its own patch and stability checks.

6. Stability & packaging

Store the bulk in a closed container in a cool, shaded place; where appropriate, assess an airless or pump pack for oxidation-sensitive systems; use batch testing to verify stability and package compatibility.

7. Claims language (Do / Don’t)

• The formulation note describes Squalane as part of a cosmetic direction focused on a light-emollient role.

• This formulation entry does not demonstrate drug claims, cure claims, or a certification that is absent from the product records.
• The ingredient note for Squalane does not confirm whitening, acne-treatment, antiperspirant, sun-protection, or hair-growth benefits.

1. INCI & CAS

INCI: Butyrospermum Parkii Butter · CAS: 91080-23-8

2. Role in the formula

The reference uses shea butter for cushion in creams, balms, and hair creams. It does not assume the color or scent of an unrefined grade.

3. Typical use levels (formulation guide)

• 2–8% is listed for creams in this reference.
• Formulation guidance for balms and butters: 10–25%.

Melt Butyrospermum Parkii Butter with the oil phase; keep shear during cooling to help prevent a grainy butter texture.

4. Regulatory sources & global compliance

• CosIng information about Butyrospermum Parkii Butter does not itself authorize a particular grade or finished cosmetic.
• The framework in Regulation (EC) No 1223/2009 requires a product-level safety assessment for the complete formula that contains Butyrospermum Parkii Butter for the product in its final form.
• Use current supplier documentation for the purchased Butyrospermum Parkii Butter grade and verify applicable destination-market filings.

5. Safety & risk assessment

The use-level note is a reference for cosmetic formulation; no drug approval or OTC-monograph status follows from this guide with patch response and finished-product stability still to be verified.

6. Stability & packaging

Store the bulk in a closed container in a cool, shaded place; choose a package with oxidation sensitivity in view; follow with stability and packaging checks on the confirmed batch.

7. Claims language (Do / Don’t)

• The recorded cosmetic positioning for Butyrospermum Parkii Butter highlights shea cushion.

• This cosmetic guide provides no basis for a drug effect, a clinical cure, or certification status not established for the SKU.
• The ingredient record for Butyrospermum Parkii Butter should not be cited in support of skin whitening, treatment of acne, sweat control, UV protection, or hair-growth results.